$0.9843
0.0014[0.14%]
At close: Apr 17
$0.9843
0[0.00%]
After Hours: 4:30PM EDT
Sensei Biotherapeutics
(NASDAQ:SNSE)Sensei Biotherapeutics Stock (NASDAQ:SNSE), Analyst Ratings, Price Targets, Predictions
Sensei Biotherapeutics Inc has a consensus price target of $6.17, established from looking at the 6 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Citigroup, and Oppenheimer on December 4, 2023, December 13, 2022, and October 3, 2022. With an average price target of $5 between HC Wainwright & Co., Citigroup, and Oppenheimer, there's an implied 407.98% upside for Sensei Biotherapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Citigroup
Oppenheimer
Piper Sandler
Berenberg
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Sensei Biotherapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/04/2023 | SNSE | Buy Now | Sensei Biotherapeutics | $0.98 | 306.38% | HC Wainwright & Co. | Edward White | → $4 | Initiates | → Buy | Get Alert |
| 12/13/2022 | SNSE | Buy Now | Sensei Biotherapeutics | $0.98 | 509.57% | Citigroup | Samantha Semenkow | → $6 | Initiates | → Buy | Get Alert |
| 10/03/2022 | SNSE | Buy Now | Sensei Biotherapeutics | $0.98 | 407.98% | Oppenheimer | Francois Brisebois | → $5 | Upgrade | Perform → Outperform | Get Alert |
| 03/10/2022 | SNSE | Buy Now | Sensei Biotherapeutics | $0.98 | 915.95% | Piper Sandler | Joseph Catanzaro | $12 → $10 | Maintains | Overweight | Get Alert |
| 07/01/2021 | SNSE | Buy Now | Sensei Biotherapeutics | $0.98 | 1119.14% | Berenberg | Zhiqiang Shu | — | Downgrade | Buy → Hold | Get Alert |
| 06/29/2021 | SNSE | Buy Now | Sensei Biotherapeutics | $0.98 | — | Oppenheimer | Kevin DeGeeter | — | Downgrade | Outperform → Perform | Get Alert |
FAQ
What is the target price for Sensei Biotherapeutics (SNSE)?
The latest price target for Sensei Biotherapeutics (NASDAQ: SNSE) was reported by HC Wainwright & Co. on December 4, 2023. The analyst firm set a price target for $4.00 expecting SNSE to rise to within 12 months (a possible 306.38% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sensei Biotherapeutics (SNSE)?
The latest analyst rating for Sensei Biotherapeutics (NASDAQ: SNSE) was provided by HC Wainwright & Co., and Sensei Biotherapeutics initiated their buy rating.
When was the last upgrade for Sensei Biotherapeutics (SNSE)?
The last upgrade for Sensei Biotherapeutics Inc happened on October 3, 2022 when Oppenheimer raised their price target to $5. Oppenheimer previously had a perform for Sensei Biotherapeutics Inc.
When was the last downgrade for Sensei Biotherapeutics (SNSE)?
The last downgrade for Sensei Biotherapeutics Inc happened on July 1, 2021 when Berenberg changed their price target from N/A to $12 for Sensei Biotherapeutics Inc.
When is the next analyst rating going to be posted or updated for Sensei Biotherapeutics (SNSE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sensei Biotherapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sensei Biotherapeutics was filed on December 4, 2023 so you should expect the next rating to be made available sometime around December 4, 2024.
Is the Analyst Rating Sensei Biotherapeutics (SNSE) correct?
While ratings are subjective and will change, the latest Sensei Biotherapeutics (SNSE) rating was a initiated with a price target of $0.00 to $4.00. The current price Sensei Biotherapeutics (SNSE) is trading at is $0.98, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.